1,127
Views
16
CrossRef citations to date
0
Altmetric
Research Paper

Public health and economic benefits of new pediatric influenza vaccination programs in Argentina

, , , , , & show all
Pages 312-322 | Received 14 Jun 2011, Accepted 30 Oct 2011, Published online: 14 Feb 2012

References

  • Fleming DM, Elliot AJ. Health benefits, risks, and cost-effectiveness of influenza vaccination in children. Pediatr Infect Dis J 2008; 27:S154 - 8; http://dx.doi.org/10.1097/INF.0b013e31818a5443; PMID: 18955891
  • Dayan GH, Nguyen VH, Debbag R, Gómez R, Wood SC. Cost-effectiveness of influenza vaccination in high-risk children in Argentina. Vaccine 2001; 19:4204 - 13; http://dx.doi.org/10.1016/S0264-410X(01)00160-8; PMID: 11457546
  • Salo H, Kilpi T, Sintonen H, Linna M, Peltola V, Heikkinen T. Cost-effectiveness of influenza vaccination of healthy children. Vaccine 2006; 24:4934 - 41; http://dx.doi.org/10.1016/j.vaccine.2006.03.057; PMID: 16678945
  • Loeb M, Russell ML, Moss L, Fonseca K, Fox J, Earn DJ, et al. Effect of influenza vaccination of children on infection rates in Hutterite communities: a randomized trial. JAMA 2010; 303:943 - 50; http://dx.doi.org/10.1001/jama.2010.250; PMID: 20215608
  • Monto AS, Davenport FM, Napier JA, Francis T Jr. Effect of vaccination of a school-age population upon the course of an A2-Hong Kong influenza epidemic. Bull World Health Organ 1969; 41:537 - 42; PMID: 5309469
  • Monto AS, Koopman JS, Longini IM Jr. Tecumseh study of illness. XIII. Influenza infection and disease, 1976–1981. Am J Epidemiol 1985; 121:811 - 22; PMID: 4014174
  • Mossong J, Hens N, Jit M, Beutels P, Auranen K, Mikolajczyk R, et al. Social contacts and mixing patterns relevant to the spread of infectious diseases. PLoS Med 2008; 5:e74; http://dx.doi.org/10.1371/journal.pmed.0050074; PMID: 18366252
  • Weycker D, Edelsberg J, Halloran ME, Longini IM Jr., Nizam A, Ciuryla V, et al. Population-wide benefits of routine vaccination of children against influenza. Vaccine 2005; 23:1284 - 93; http://dx.doi.org/10.1016/j.vaccine.2004.08.044; PMID: 15652671
  • Hibbert CL, Piedra PA, McLaurin KK, Vesikari T, Mauskopf J, Mahadevia PJ. Cost-effectiveness of live-attenuated influenza vaccine, trivalent in preventing influenza in young children attending day-care centres. Vaccine 2007; 25:8010 - 20; http://dx.doi.org/10.1016/j.vaccine.2007.09.018; PMID: 17936446
  • Elveback LR, Fox JP, Ackerman E, Langworthy A, Boyd M, Gatewood L. An influenza simulation model for immunization studies. Am J Epidemiol 1976; 103:152 - 65; PMID: 814808
  • Halloran ME, Longini IM, Cowart DM, Nizam A. Community interventions and the epidemic prevention potential. Vaccine 2002; 20:3254 - 62; http://dx.doi.org/10.1016/S0264-410X(02)00316-X; PMID: 12213394
  • Longini IM, Halloran ME, Nizam A, Wolff M, Mendelman PM, Fast PE, et al. Estimation of the efficacy of live, attenuated influenza vaccine from a two-year, multi-center vaccine trial: implications for influenza epidemic control. Vaccine 2000; 18:1902 - 9; http://dx.doi.org/10.1016/S0264-410X(99)00419-3; PMID: 10699339
  • Walsh JA, Maher C. Economic Implications of Influenza and Influenza Vaccine. In: Influenza Vaccines for the Future; 2011:425-440.
  • Libster R, Bugna J, Coviello S, Hijano DR, Dunaiewsky M, Reynoso N, et al. Pediatric hospitalizations associated with 2009 pandemic influenza A (H1N1) in Argentina. N Engl J Med 2010; 362:45 - 55; http://dx.doi.org/10.1056/NEJMoa0907673; PMID: 20032320
  • Ministerio De Salud De La Nación. Influenza pandémica (H1N1) 2009. República Argentina. 2010.
  • Gentile AS De, Ponte Jose M Del. Consenso sobre Actualidad en Vacunas: comité Nacional de Infectología / Updated vaccines consensus. 1998; 96:52-79.
  • de Lataillade C, Auvergne S, Delannoy I. 2005 and 2006 seasonal influenza vaccination coverage rates in 10 countries in Africa, Asia Pacific, Europe, Latin America and the Middle East. J Public Health Policy 2009; 30:83 - 101; http://dx.doi.org/10.1057/jphp.2008.40; PMID: 19367303
  • United Nations. World Population Prospects: 2008 Revision Population Database. 2010 estimate. Available at: http://esa.un.org/unpp/p2k0data.asp.
  • van Hoek AJ, Underwood A, Jit M, Miller E, Edmunds WJ. The impact of pandemic influenza H1N1 on health-related quality of life: a prospective population-based study. PLoS ONE 2011; 6:e17030; http://dx.doi.org/10.1371/journal.pone.0017030; PMID: 21399678
  • Wailoo AJ, Sutton AJ, Cooper NJ, Turner DA, Abrams KR, Brennan A, et al. Cost-effectiveness and value of information analyses of neuraminidase inhibitors for the treatment of influenza. Value Health 2008; 11:160 - 71; http://dx.doi.org/10.1111/j.1524-4733.2007.00241.x; PMID: 18380629
  • Ministerio De Salud De La Nación. Estadisticas Vitales—Informacion Basica Año. 2006.
  • INDEC. Censo Nacional de Población, Hogares y Viviendas. 2008.
  • Grupo Colaborativo de Vigilancia Epidemiológica de la Gripe en Argentina. Argentinean Boletin Epidemiologico 2002–2006. Available at: http://www.grog-argentina.org/grog/front/templates/affich.jsp?siteCode=GROG_LOCAL_ARGENTINA&lang=ES&codeRubrique=11.
  • World Health Organisation. Threshold values for intervention cost-effectiveness by Region. 2010. Available at: http://www.who.int/choice/costs/CER_levels/en/index.html.
  • Califano G. Vacuna antigripal. In: Sociedad Argentina de Pediatría, Comité Nacional de Infectología, eds. PRIORIDADES PARA LA INCORPORACIÓN DE VACUNAS AL CALENDARIO NACIONAL.; 2011:123-135.
  • Jefferson TO, Rivetti D, Di Pietrantonj C, Rivetti A, Demicheli V. Vaccines for preventing influenza in healthy adults. Cochrane Database Syst Rev 2007; CD001269; PMID: 17443504
  • Prosser LA, Bridges CB, Uyeki TM, Hinrichsen VL, Meltzer MI, Molinari NA, et al. Health benefits, risks, and cost-effectiveness of influenza vaccination of children. Emerg Infect Dis 2006; 12:1548 - 58; http://dx.doi.org/10.3201/eid1210.051015; PMID: 17176570
  • Turner D, Wailoo A, Nicholson K, Cooper N, Sutton A, Abrams K. Systematic review and economic decision modelling for the prevention and treatment of influenza A and B. Health Technol Assess 2003; 7:iii - iv xi - xiii 1 - 170; PMID: 14609480
  • Prosser LA, O’Brien MA, Molinari NA, Hohman KH, Nichol KL, Messonnier ML, et al. Non-traditional settings for influenza vaccination of adults: costs and cost effectiveness. Pharmacoeconomics 2008; 26:163 - 78; http://dx.doi.org/10.2165/00019053-200826020-00006; PMID: 18198935
  • Ryan J, Zoellner Y, Gradl B, Palache B, Medema J. Establishing the health and economic impact of influenza vaccination within the European Union 25 countries. Vaccine 2006; 24:6812 - 22; http://dx.doi.org/10.1016/j.vaccine.2006.07.042; PMID: 17034909
  • Rothberg MBB, He S, Rose DNN. Management of influenza symptoms in healthy adults. J Gen Intern Med 2003; 18:808 - 15; http://dx.doi.org/10.1046/j.1525-1497.2003.20822.x; PMID: 14521643
  • Augustovski FA, Irazola V, Velasquez A, Gibbons L, Craig B. Argentine valuation of the EQ-5D health states. Value Health 2009; 12:587 - 96; http://dx.doi.org/10.1111/j.1524-4733.2008.00468.x; PMID: 19900257
  • Manzoli L, Schioppa F, Boccia A, Villari P. The efficacy of influenza vaccine for healthy children: a meta-analysis evaluating potential sources of variation in efficacy estimates including study quality. Pediatr Infect Dis J 2007; 26:97 - 106; http://dx.doi.org/10.1097/01.inf.0000253053.01151.bd; PMID: 17259870
  • Negri E, Colombo C, Giordano L, Groth N, Apolone G, La Vecchia C. Influenza vaccine in healthy children: a meta-analysis. Vaccine 2005; 23:2851 - 61; http://dx.doi.org/10.1016/j.vaccine.2004.11.053; PMID: 15780733
  • Villari P, Manzoli L, Boccia A. Methodological quality of studies and patient age as major sources of variation in efficacy estimates of influenza vaccination in healthy adults: a meta-analysis. Vaccine 2004; 22:3475 - 86; http://dx.doi.org/10.1016/j.vaccine.2004.01.068; PMID: 15308375
  • Jefferson T, Rivetti D, Rivetti A, Rudin M, Di Pietrantonj C, Demicheli V. Efficacy and effectiveness of influenza vaccines in elderly people: a systematic review. Lancet 2005; 366:1165 - 74; http://dx.doi.org/10.1016/S0140-6736(05)67339-4; PMID: 16198765
  • Nichol KL, Nordin JD, Nelson DB, Mullooly JP, Hak E. Effectiveness of influenza vaccine in the community-dwelling elderly. N Engl J Med 2007; 357:1373 - 81; http://dx.doi.org/10.1056/NEJMoa070844; PMID: 17914038
  • Rivetti D, Jefferson T, Thomas R, Rudin M, Rivetti A, Di Pietrantonj C, et al. Vaccines for preventing influenza in the elderly. Cochrane Database Syst Rev 2006; 3:CD004876; PMID: 16856068
  • Vu T, Farish S, Jenkins M, Kelly H. A meta-analysis of effectiveness of influenza vaccine in persons aged 65 years and over living in the community. Vaccine 2002; 20:1831 - 6; http://dx.doi.org/10.1016/S0264-410X(02)00041-5; PMID: 11906772
  • Pan American Health Organisation (PAHO). No Title. 2009. Available at: http://new.paho.org/hq/.
  • Giglio ND, Cane AD, Micone P, Gentile A. Cost-effectiveness of the CRM-based 7-valent pneumococcal conjugated vaccine (PCV7) in Argentina. Vaccine 2010; 28:2302 - 10; http://dx.doi.org/10.1016/j.vaccine.2009.12.070; PMID: 20064478
  • Press WH, Teukolsky SA, Vetterling WT, Flannery BP. Numerical Recipes: The Art of Scientific Computing. 3rd ed. New York: Cambridge University Press; 2007.